Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
An open-label phase 2 clinical trial of topical remetinostat gel for basal cell carcinoma Urman, N., Eichstadt, S., Do, H., Mirza, A. N., Li, S., Oro, A., Aasi, S., Sarin, K. Y. ELSEVIER SCIENCE INC. 2019: S171
View details for Web of Science ID 000465561505130